Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · IEX Real-Time Price · USD
8.00
-0.12 (-1.48%)
At close: Jul 19, 2024, 4:00 PM
7.89
-0.11 (-1.38%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $497.23 million as of July 22, 2024. Its market cap has increased by 138.94% in one year.
Market Cap
497.23M
Enterprise Value
292.85M
1-Year Change
138.94%
Ranking
Category
Stock Price
$8.00
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has increased from $315.10M to $497.23M, an increase of 57.80%. That is a compound annual growth rate of 9.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 497.20M | 19.15% |
Dec 29, 2023 | 417.30M | 10.13% |
Dec 30, 2022 | 378.90M | -47.18% |
Dec 31, 2021 | 717.30M | 123.04% |
Dec 31, 2020 | 321.60M | -17.20% |
Dec 31, 2019 | 388.40M | 23.26% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Contineum Therapeutics | 518.32M |
GRAIL, LLC | 514.79M |
Y-mAbs Therapeutics | 508.60M |
COMPASS Pathways | 498.90M |
Sharecare | 498.83M |
Jin Medical International | 490.78M |
Heron Therapeutics | 489.62M |
Oculis Holding AG | 488.72M |